NO20041984L - Stenter - Google Patents
StenterInfo
- Publication number
- NO20041984L NO20041984L NO20041984A NO20041984A NO20041984L NO 20041984 L NO20041984 L NO 20041984L NO 20041984 A NO20041984 A NO 20041984A NO 20041984 A NO20041984 A NO 20041984A NO 20041984 L NO20041984 L NO 20041984L
- Authority
- NO
- Norway
- Prior art keywords
- stents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10152460A DE10152460A1 (de) | 2001-10-24 | 2001-10-24 | Stents |
| PCT/EP2002/011402 WO2003035133A1 (de) | 2001-10-24 | 2002-10-11 | Stents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20041984L true NO20041984L (no) | 2004-05-13 |
Family
ID=7703557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20041984A NO20041984L (no) | 2001-10-24 | 2004-05-13 | Stenter |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050064006A1 (pl) |
| EP (1) | EP1439869A1 (pl) |
| JP (1) | JP2005506151A (pl) |
| KR (1) | KR20040074977A (pl) |
| CN (1) | CN1575189A (pl) |
| AU (1) | AU2002340549B2 (pl) |
| BR (1) | BR0213481A (pl) |
| CA (1) | CA2464290A1 (pl) |
| DE (1) | DE10152460A1 (pl) |
| EC (1) | ECSP045075A (pl) |
| EE (1) | EE200400080A (pl) |
| HR (1) | HRP20040456A2 (pl) |
| HU (1) | HUP0401760A3 (pl) |
| IL (1) | IL161445A0 (pl) |
| MA (1) | MA26341A1 (pl) |
| MX (1) | MXPA04003755A (pl) |
| NO (1) | NO20041984L (pl) |
| NZ (1) | NZ532443A (pl) |
| PL (1) | PL367968A1 (pl) |
| RU (1) | RU2004115757A (pl) |
| WO (1) | WO2003035133A1 (pl) |
| ZA (1) | ZA200402989B (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
| DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| DE10355461A1 (de) * | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
| DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
| EP1685841A1 (en) * | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
| DE102005045518A1 (de) * | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
| DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
| DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
| SG166126A1 (en) | 2005-10-04 | 2010-11-29 | Bayer Schering Pharma Ag | Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| US20070097252A1 (en) * | 2005-10-31 | 2007-05-03 | Silverstein D A | Imaging methods, cameras, projectors, and articles of manufacture |
| DE102006034916A1 (de) * | 2006-07-28 | 2008-01-31 | Bayer Healthcare Ag | Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten |
| DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
| EP2220079A2 (en) | 2007-11-15 | 2010-08-25 | Boehringer Ingelheim International GmbH | Substituted amides, manufacturing and use thereof as medicaments |
| US11654036B2 (en) | 2020-05-26 | 2023-05-23 | Elixir Medical Corporation | Anticoagulant compounds and methods and devices for their use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2134870T3 (es) * | 1993-05-01 | 1999-10-16 | Merck Patent Gmbh | Antagonistas del receptor de adhesion. |
| US6133256A (en) * | 1997-04-14 | 2000-10-17 | Cor Therapeutics Inc | Selective factor Xa inhibitors |
| US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
| US20010029351A1 (en) * | 1998-04-16 | 2001-10-11 | Robert Falotico | Drug combinations and delivery devices for the prevention and treatment of vascular disease |
| DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE10105989A1 (de) * | 2001-02-09 | 2002-08-14 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
-
2001
- 2001-10-24 DE DE10152460A patent/DE10152460A1/de not_active Withdrawn
-
2002
- 2002-02-11 IL IL16144502A patent/IL161445A0/xx unknown
- 2002-10-11 JP JP2003537695A patent/JP2005506151A/ja active Pending
- 2002-10-11 US US10/493,552 patent/US20050064006A1/en not_active Abandoned
- 2002-10-11 KR KR10-2004-7006051A patent/KR20040074977A/ko not_active Application Discontinuation
- 2002-10-11 WO PCT/EP2002/011402 patent/WO2003035133A1/de active IP Right Grant
- 2002-10-11 PL PL02367968A patent/PL367968A1/pl not_active Application Discontinuation
- 2002-10-11 RU RU2004115757/15A patent/RU2004115757A/ru not_active Application Discontinuation
- 2002-10-11 EP EP02774699A patent/EP1439869A1/de not_active Withdrawn
- 2002-10-11 EE EEP200400080A patent/EE200400080A/xx unknown
- 2002-10-11 CN CNA028210034A patent/CN1575189A/zh active Pending
- 2002-10-11 CA CA002464290A patent/CA2464290A1/en not_active Abandoned
- 2002-10-11 AU AU2002340549A patent/AU2002340549B2/en not_active Ceased
- 2002-10-11 HU HU0401760A patent/HUP0401760A3/hu unknown
- 2002-10-11 NZ NZ532443A patent/NZ532443A/en unknown
- 2002-10-11 MX MXPA04003755A patent/MXPA04003755A/es not_active Application Discontinuation
- 2002-10-11 BR BR0213481-0A patent/BR0213481A/pt not_active IP Right Cessation
-
2004
- 2004-04-20 ZA ZA200402989A patent/ZA200402989B/en unknown
- 2004-04-22 EC EC2004005075A patent/ECSP045075A/es unknown
- 2004-04-23 MA MA27648A patent/MA26341A1/fr unknown
- 2004-05-13 NO NO20041984A patent/NO20041984L/no not_active Application Discontinuation
- 2004-05-21 HR HR20040456A patent/HRP20040456A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0213481A (pt) | 2004-11-03 |
| DE10152460A1 (de) | 2003-05-08 |
| MXPA04003755A (es) | 2004-07-23 |
| PL367968A1 (pl) | 2005-03-07 |
| MA26341A1 (fr) | 2004-10-01 |
| EE200400080A (et) | 2004-08-16 |
| AU2002340549B2 (en) | 2007-11-29 |
| ECSP045075A (es) | 2004-05-28 |
| KR20040074977A (ko) | 2004-08-26 |
| HRP20040456A2 (en) | 2005-06-30 |
| RU2004115757A (ru) | 2005-04-10 |
| CA2464290A1 (en) | 2003-05-01 |
| HUP0401760A2 (hu) | 2004-12-28 |
| EP1439869A1 (de) | 2004-07-28 |
| ZA200402989B (en) | 2005-04-20 |
| NZ532443A (en) | 2005-11-25 |
| WO2003035133A1 (de) | 2003-05-01 |
| US20050064006A1 (en) | 2005-03-24 |
| IL161445A0 (en) | 2004-09-27 |
| HUP0401760A3 (en) | 2008-04-28 |
| CN1575189A (zh) | 2005-02-02 |
| JP2005506151A (ja) | 2005-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50105476D1 (de) | Stent | |
| EE200100132A (xx) | Stent | |
| EE200100304A (xx) | Stent | |
| DE60236093D1 (de) | Entfernbarer stent | |
| DE60332977D1 (de) | Endoprothese | |
| DE60238422D1 (de) | Optimierte dosierung bei paclitaxelhaltigen stents | |
| ATE555761T1 (de) | Absorbierender artikel | |
| DE60209850D1 (de) | Absorbierender Artikel | |
| DE60214783D1 (de) | Absorbierender Gegenstand | |
| FI20010694A0 (fi) | Implantti | |
| ATE319451T1 (de) | Tetrahydrochinolin-derivate | |
| ATE524462T1 (de) | C5-modifizierte indazolylpyrrolotriazine | |
| ATE266873T1 (de) | Beschichtete gegenstände | |
| ATE312827T1 (de) | 3-substituierte-4-pyrimidonderivate | |
| DE60225452D1 (de) | Wiederverschliessbarer absorbierender artikel | |
| DE60214255D1 (de) | Schlussstück | |
| NO20041984L (no) | Stenter | |
| DE60215580D1 (de) | Absorbierender Artikel | |
| DE60223031D1 (de) | Arylpiperazin gebundene tetrahydroindolonderivate | |
| DE50113918D1 (de) | Quengel-Orthese | |
| DE60202381D1 (de) | Paroxetin-n-formyl-derivate | |
| FR2825911B1 (fr) | Implant cotyloidien | |
| FR2803509B1 (fr) | Prothese metatarso-phalangienne | |
| DE60136218D1 (de) | Stentablegesystem | |
| DE50201746D1 (de) | Prothese |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |